Last but not least, several studies have reported an upregulation of PD-L1 in the tumor micromillieu following RT, which is known to interfere with the effector functions of T cells, to assist in the immune escape of tumors and to result in treatment failure [38,59,60,61,62]. This evidence concerns the gene CD274 and neoplasm.